142 related articles for article (PubMed ID: 11201608)
1. Localization of hepatocyte growth factor activator inhibitor type 1 in Langhans' cells of human placenta.
Kataoka H; Meng JY; Itoh H; Hamasuna R; Shimomura T; Suganuma T; Koono M
Histochem Cell Biol; 2000 Dec; 114(6):469-75. PubMed ID: 11201608
[TBL] [Abstract][Full Text] [Related]
2. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma.
Yamauchi M; Kataoka H; Itoh H; Seguchi T; Hasui Y; Osada Y
J Urol; 2004 Feb; 171(2 Pt 1):890-6. PubMed ID: 14713848
[TBL] [Abstract][Full Text] [Related]
4. Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells.
Parr C; Jiang WG
Int J Oncol; 2001 Oct; 19(4):857-63. PubMed ID: 11562767
[TBL] [Abstract][Full Text] [Related]
5. The hepatocyte growth factor regulatory factors in human breast cancer.
Parr C; Watkins G; Mansel RE; Jiang WG
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):202-11. PubMed ID: 14734471
[TBL] [Abstract][Full Text] [Related]
6. Expression of hepatocyte growth factor activator inhibitor type 1 in endothelial cells.
Akiyama Y; Nagai M; Komaki W; Marutsuka K; Asada Y; Kataoka H
Hum Cell; 2006 Aug; 19(3):91-7. PubMed ID: 17204092
[TBL] [Abstract][Full Text] [Related]
7. Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis.
Marchand-Adam S; Fabre A; Mailleux AA; Marchal J; Quesnel C; Kataoka H; Aubier M; Dehoux M; Soler P; Crestani B
Am J Respir Crit Care Med; 2006 Jul; 174(1):58-66. PubMed ID: 16574935
[TBL] [Abstract][Full Text] [Related]
8. Augmented expression of hepatocytes growth factor activator inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis.
Sasaki M; Ikeda H; Kataoka H; Nakanuma Y
Virchows Arch; 2006 Oct; 449(4):462-71. PubMed ID: 16941151
[TBL] [Abstract][Full Text] [Related]
9. Mouse hepatocyte growth factor (HGF) activator inhibitor type 2 lacking the first Kunitz domain potently inhibits the HGF activator.
Kataoka H; Itoh H; Nuki Y; Hamasuna R; Naganuma S; Kitamura N; Shimomura T
Biochem Biophys Res Commun; 2002 Jan; 290(3):1096-100. PubMed ID: 11798188
[TBL] [Abstract][Full Text] [Related]
10. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.
Kirchhofer D; Peek M; Li W; Stamos J; Eigenbrot C; Kadkhodayan S; Elliott JM; Corpuz RT; Lazarus RA; Moran P
J Biol Chem; 2003 Sep; 278(38):36341-9. PubMed ID: 12815039
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment.
Kataoka H; Shimomura T; Kawaguchi T; Hamasuna R; Itoh H; Kitamura N; Miyazawa K; Koono M
J Biol Chem; 2000 Dec; 275(51):40453-62. PubMed ID: 11013244
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.
Parr C; Jiang WG
Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597
[TBL] [Abstract][Full Text] [Related]
13. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor.
Kawaguchi T; Qin L; Shimomura T; Kondo J; Matsumoto K; Denda K; Kitamura N
J Biol Chem; 1997 Oct; 272(44):27558-64. PubMed ID: 9346890
[TBL] [Abstract][Full Text] [Related]
14. Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa.
Itoh H; Kataoka H
J Gastroenterol; 2002 Nov; 37 Suppl 14():15-21. PubMed ID: 12572861
[TBL] [Abstract][Full Text] [Related]
15. Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma.
Nagata K; Hirono S; Ido A; Kataoka H; Moriuchi A; Shimomura T; Hori T; Hayashi K; Koono M; Kitamura N; Tsubouchi H
Biochem Biophys Res Commun; 2001 Nov; 289(1):205-11. PubMed ID: 11708800
[TBL] [Abstract][Full Text] [Related]
16. Pericellular activation of hepatocyte growth factor/scatter factor (HGF/SF) in colorectal carcinomas: roles of HGF activator (HGFA) and HGFA inhibitor type 1 (HAI-1).
Kataoka H; Itoh H; Hamasuna R; Meng JY; Koono M
Hum Cell; 2001 Mar; 14(1):83-93. PubMed ID: 11436357
[TBL] [Abstract][Full Text] [Related]
17. Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor.
Kataoka H; Miyata S; Uchinokura S; Itoh H
Cancer Metastasis Rev; 2003; 22(2-3):223-36. PubMed ID: 12784998
[TBL] [Abstract][Full Text] [Related]
18. Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.
Kohama K; Kawaguchi M; Fukushima T; Lin CY; Kataoka H
Hum Cell; 2012 Dec; 25(4):100-10. PubMed ID: 23248048
[TBL] [Abstract][Full Text] [Related]
19. Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice.
Phin S; Marchand-Adam S; Fabre A; Marchal-Somme J; Bantsimba-Malanda C; Kataoka H; Soler P; Crestani B
Am J Respir Cell Mol Biol; 2010 Mar; 42(3):286-93. PubMed ID: 19448157
[TBL] [Abstract][Full Text] [Related]
20. Expression of hepatocyte growth factor activator inhibitor type 2 (HAI-2) in human testis: identification of a distinct transcription start site for the HAI-2 gene in testis.
Yamauchi M; Itoh H; Naganuma S; Koono M; Hasui Y; Osada Y; Kataoka H
Biol Chem; 2002 Dec; 383(12):1953-7. PubMed ID: 12553733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]